The first cell-based and label-free, high-throughput assay of specific enzyme activities
Award amount
$224,818Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SAMDI TECH, INC.
- Proposal award date
- 2018-03-01
- Contract end date
- 2018-11-30
- UEI
- NE8BL1NFZRF9
- Solicitation number
- PA17-302
- Topic code
- 950
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of the first label-free and high-throughput, cell-based assay that reports on specific enzyme activities
- Traceless immobilization and SAMDI mass spectrometry enables high-throughput screening of any analyte.
- Self-Assembled Monolayers with Matrix-assisted Laser Desorption Ionization (SAMDI) Sensors
- SBIR Phase I: A Label-Free Tool for High Throughput Drug Discovery
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need
- Tolerability of SRX246 in Huntington's Disease Patients
- Tolerability of SRX246 in Huntington's Disease Patients
Research funding history
5 SBIR/STTR records share this UEI (2011–2020). Reported award amounts total $3,215,332. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation